AKZO NOBEL N.V. (AKZA.AS) Stock Fundamental Analysis

Europe • Euronext Amsterdam • AMS:AKZA • NL0013267909

57.88 EUR
+0.94 (+1.65%)
Last: Feb 4, 2026, 10:33 AM
Fundamental Rating

4

Taking everything into account, AKZA scores 4 out of 10 in our fundamental rating. AKZA was compared to 68 industry peers in the Chemicals industry. There are concerns on the financial health of AKZA while its profitability can be described as average. AKZA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • AKZA had positive earnings in the past year.
  • AKZA had a positive operating cash flow in the past year.
  • In the past 5 years AKZA has always been profitable.
  • Each year in the past 5 years AKZA had a positive operating cash flow.
AKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFAKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

  • AKZA has a Return On Assets (0.42%) which is comparable to the rest of the industry.
  • AKZA has a Return On Equity (1.48%) which is in line with its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.70%, AKZA is in line with its industry, outperforming 54.41% of the companies in the same industry.
  • AKZA had an Average Return On Invested Capital over the past 3 years of 5.38%. This is in line with the industry average of 6.72%.
Industry RankSector Rank
ROA 0.42%
ROE 1.48%
ROIC 3.7%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
AKZA.AS Yearly ROA, ROE, ROICAKZA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

  • With a Profit Margin value of 0.56%, AKZA perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
  • In the last couple of years the Profit Margin of AKZA has declined.
  • AKZA's Operating Margin of 4.84% is in line compared to the rest of the industry. AKZA outperforms 54.41% of its industry peers.
  • In the last couple of years the Operating Margin of AKZA has remained more or less at the same level.
  • AKZA has a Gross Margin (39.78%) which is in line with its industry peers.
  • AKZA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.84%
PM (TTM) 0.56%
GM 39.78%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
AKZA.AS Yearly Profit, Operating, Gross MarginsAKZA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AKZA is destroying value.
  • The number of shares outstanding for AKZA remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for AKZA has been reduced compared to 5 years ago.
  • The debt/assets ratio for AKZA has been reduced compared to a year ago.
AKZA.AS Yearly Shares OutstandingAKZA.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AKZA.AS Yearly Total Debt VS Total AssetsAKZA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • AKZA has an Altman-Z score of 2.04. This is not the best score and indicates that AKZA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • AKZA's Altman-Z score of 2.04 is on the low side compared to the rest of the industry. AKZA is outperformed by 60.29% of its industry peers.
  • The Debt to FCF ratio of AKZA is 10.17, which is on the high side as it means it would take AKZA, 10.17 years of fcf income to pay off all of its debts.
  • AKZA's Debt to FCF ratio of 10.17 is in line compared to the rest of the industry. AKZA outperforms 55.88% of its industry peers.
  • A Debt/Equity ratio of 0.93 indicates that AKZA is somewhat dependend on debt financing.
  • AKZA has a worse Debt to Equity ratio (0.93) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 10.17
Altman-Z 2.04
ROIC/WACC0.62
WACC5.96%
AKZA.AS Yearly LT Debt VS Equity VS FCFAKZA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • AKZA has a Current Ratio of 1.25. This is a normal value and indicates that AKZA is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.25, AKZA is not doing good in the industry: 76.47% of the companies in the same industry are doing better.
  • AKZA has a Quick Ratio of 1.25. This is a bad value and indicates that AKZA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AKZA has a worse Quick ratio (0.92) than 60.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.92
AKZA.AS Yearly Current Assets VS Current LiabilitesAKZA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

4

3. Growth

3.1 Past

  • The earnings per share for AKZA have decreased strongly by -16.03% in the last year.
  • Measured over the past 5 years, AKZA shows a small growth in Earnings Per Share. The EPS has been growing by 4.44% on average per year.
  • AKZA shows a small growth in Revenue. In the last year, the Revenue has grown by 0.40%.
  • AKZA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.92% yearly.
EPS 1Y (TTM)-16.03%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%-66.67%
Revenue 1Y (TTM)0.4%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-10.56%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.81% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 3.75% on average over the next years.
EPS Next Y0.31%
EPS Next 2Y6.19%
EPS Next 3Y7.34%
EPS Next 5Y8.81%
Revenue Next Year-3.31%
Revenue Next 2Y-2.08%
Revenue Next 3Y0.46%
Revenue Next 5Y3.75%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AKZA.AS Yearly Revenue VS EstimatesAKZA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
AKZA.AS Yearly EPS VS EstimatesAKZA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 17.70, which indicates a rather expensive current valuation of AKZA.
  • 76.47% of the companies in the same industry are more expensive than AKZA, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 28.18. AKZA is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio of 13.20, the valuation of AKZA can be described as correct.
  • Based on the Price/Forward Earnings ratio, AKZA is valued cheaper than 85.29% of the companies in the same industry.
  • AKZA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 25.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.7
Fwd PE 13.2
AKZA.AS Price Earnings VS Forward Price EarningsAKZA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AKZA indicates a slightly more expensive valuation: AKZA is more expensive than 63.24% of the companies listed in the same industry.
  • AKZA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AKZA is cheaper than 77.94% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.82
EV/EBITDA 15.68
AKZA.AS Per share dataAKZA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AKZA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)57.04
PEG (5Y)3.98
EPS Next 2Y6.19%
EPS Next 3Y7.34%

More info and screens

3

5. Dividend

5.1 Amount

  • AKZA has a Yearly Dividend Yield of 3.35%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.28, AKZA pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.83, AKZA pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.35%

5.2 History

  • The dividend of AKZA decreases each year by -21.52%.
Dividend Growth(5Y)-21.52%
Div Incr Years0
Div Non Decr Years4
AKZA.AS Yearly Dividends per shareAKZA.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

  • AKZA pays out 691.38% of its income as dividend. This is not a sustainable payout ratio.
DP691.38%
EPS Next 2Y6.19%
EPS Next 3Y7.34%
AKZA.AS Yearly Income VS Free CF VS DividendAKZA.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
AKZA.AS Dividend Payout.AKZA.AS Dividend Payout, showing the Payout Ratio.AKZA.AS Dividend Payout.PayoutRetained Earnings

More info and screens

AKZO NOBEL N.V.

AMS:AKZA (2/4/2026, 10:33:19 AM)

57.88

+0.94 (+1.65%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-22
Earnings (Next)02-03
Inst Owners73.9%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap9.90B
Revenue(TTM)10.71B
Net Income(TTM)58.00M
Analysts74.78
Price Target70.24 (21.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.35%
Yearly Dividend1.98
Dividend Growth(5Y)-21.52%
DP691.38%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.89%
Min EPS beat(2)-7.4%
Max EPS beat(2)-6.38%
EPS beat(4)0
Avg EPS beat(4)-11.39%
Min EPS beat(4)-27.6%
Max EPS beat(4)-4.18%
EPS beat(8)1
Avg EPS beat(8)-8.1%
EPS beat(12)2
Avg EPS beat(12)-11.74%
EPS beat(16)4
Avg EPS beat(16)-11.18%
Revenue beat(2)0
Avg Revenue beat(2)-3.03%
Min Revenue beat(2)-5.13%
Max Revenue beat(2)-0.93%
Revenue beat(4)1
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-5.13%
Max Revenue beat(4)1.79%
Revenue beat(8)1
Avg Revenue beat(8)-1.51%
Revenue beat(12)3
Avg Revenue beat(12)-1.43%
Revenue beat(16)3
Avg Revenue beat(16)-1.57%
PT rev (1m)-0.01%
PT rev (3m)-1.2%
EPS NQ rev (1m)-7.7%
EPS NQ rev (3m)-15.88%
EPS NY rev (1m)-2.9%
EPS NY rev (3m)-8.1%
Revenue NQ rev (1m)-1.04%
Revenue NQ rev (3m)-2.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE 17.7
Fwd PE 13.2
P/S 0.95
P/FCF 18.82
P/OCF 11.66
P/B 2.52
P/tB 67.81
EV/EBITDA 15.68
EPS(TTM)3.27
EY5.65%
EPS(NY)4.39
Fwd EY7.58%
FCF(TTM)3.08
FCFY5.31%
OCF(TTM)4.96
OCFY8.58%
SpS60.83
BVpS22.98
TBVpS0.85
PEG (NY)57.04
PEG (5Y)3.98
Graham Number41.12
Profitability
Industry RankSector Rank
ROA 0.42%
ROE 1.48%
ROCE 5.56%
ROIC 3.7%
ROICexc 4.33%
ROICexgc 8.48%
OM 4.84%
PM (TTM) 0.56%
GM 39.78%
FCFM 5.06%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
ROICexc(3y)6.53%
ROICexc(5y)7.21%
ROICexgc(3y)12.06%
ROICexgc(5y)13.03%
ROCE(3y)9.71%
ROCE(5y)10.22%
ROICexgc growth 3Y-10.53%
ROICexgc growth 5Y-0.19%
ROICexc growth 3Y-9.99%
ROICexc growth 5Y-0.31%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 10.17
Debt/EBITDA 4.17
Cap/Depr 86.36%
Cap/Sales 3.1%
Interest Coverage 2.86
Cash Conversion 96.7%
Profit Quality 906.9%
Current Ratio 1.25
Quick Ratio 0.92
Altman-Z 2.04
F-Score5
WACC5.96%
ROIC/WACC0.62
Cap/Depr(3y)80.65%
Cap/Depr(5y)79.09%
Cap/Sales(3y)2.74%
Cap/Sales(5y)2.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.03%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%-66.67%
EPS Next Y0.31%
EPS Next 2Y6.19%
EPS Next 3Y7.34%
EPS Next 5Y8.81%
Revenue 1Y (TTM)0.4%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-10.56%
Revenue Next Year-3.31%
Revenue Next 2Y-2.08%
Revenue Next 3Y0.46%
Revenue Next 5Y3.75%
EBIT growth 1Y-49.8%
EBIT growth 3Y-6.39%
EBIT growth 5Y1.75%
EBIT Next Year30.04%
EBIT Next 3Y15.63%
EBIT Next 5Y9.36%
FCF growth 1Y-8.04%
FCF growth 3Y4.63%
FCF growth 5YN/A
OCF growth 1Y1.07%
OCF growth 3Y3.41%
OCF growth 5Y96.16%

AKZO NOBEL N.V. / AKZA.AS FAQ

What is the ChartMill fundamental rating of AKZO NOBEL N.V. (AKZA.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKZA.AS.


What is the valuation status for AKZA stock?

ChartMill assigns a valuation rating of 4 / 10 to AKZO NOBEL N.V. (AKZA.AS). This can be considered as Fairly Valued.


What is the profitability of AKZA stock?

AKZO NOBEL N.V. (AKZA.AS) has a profitability rating of 4 / 10.


What is the financial health of AKZO NOBEL N.V. (AKZA.AS) stock?

The financial health rating of AKZO NOBEL N.V. (AKZA.AS) is 3 / 10.


What is the earnings growth outlook for AKZO NOBEL N.V.?

The Earnings per Share (EPS) of AKZO NOBEL N.V. (AKZA.AS) is expected to grow by 0.31% in the next year.